Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Phytocannabinoid-rich galenic preparations for topical administration: extraction and stability testing

D. Kaczorová, J. Peč, T. Béres, N. Štefelová, S. Ćavar Zeljković, V. Trojan, AK. Janatová, P. Klouček, P. Tarkowski

. 2023 ; 14 (-) : 1230728. [pub] 20230801

Status not-indexed Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc23015549

Although medical cannabis was legalized in Czechia in 2013 and its use in topical treatments of skin disorders is now allowed, galenic formulations prepared from medical cannabis have not been widely implemented in the Czech healthcare system. One of the main reasons is the lack of a straightforward standardized protocol for their preparation. Cannabinoids, e.g., cannabidiol (CBD) and tetrahydrocannabinol (THC), have been shown to have therapeutic effects on various skin conditions, such as atopic dermatitis, psoriasis, scleroderma, acne and skin pigmentation. Recognizing the potential of dermatological treatment with medical cannabis, the present study aimed to evaluate the extraction capacity of various pharmaceutical bases for cannabinoids and the stability of prepared galenic formulations for dermatological applications with respect to cannabinoid content. The results showed that the stability of cannabinoids in formulations depended on the bases' physical and chemical properties. The highest THC decomposition was observed in cream bases and Vaseline, with estimated percentage loss of total content of up to 5.4% and 5.6% per week, respectively. In contrast, CBD was more stable than THC. Overall, the tested bases were comparably effective in extracting cannabinoids from plant material. However, olive oil and Synderman bases exhibited the highest cannabinoid extraction efficiencies (approximately 70%) and the best storage stabilities in terms of the content of monitored compounds. The proposed preparation protocol is fast and easily implementable in pharmacies and medical facilities.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23015549
003      
CZ-PrNML
005      
20231020093454.0
007      
ta
008      
231010s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fphar.2023.1230728 $2 doi
035    __
$a (PubMed)37593173
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kaczorová, Dominika $u Czech Advanced Technology and Research Institute, Palacký University, Olomouc, Czechia $u Department of Genetic Resources for Vegetables, Medicinal and Special Plants, Centre of the Region Haná for Biotechnological and Agricultural Research, Crop Research Institute, Olomouc, Czechia $u Department of Biochemistry, Faculty of Science, Palacký University, Olomouc, Czechia
245    10
$a Phytocannabinoid-rich galenic preparations for topical administration: extraction and stability testing / $c D. Kaczorová, J. Peč, T. Béres, N. Štefelová, S. Ćavar Zeljković, V. Trojan, AK. Janatová, P. Klouček, P. Tarkowski
520    9_
$a Although medical cannabis was legalized in Czechia in 2013 and its use in topical treatments of skin disorders is now allowed, galenic formulations prepared from medical cannabis have not been widely implemented in the Czech healthcare system. One of the main reasons is the lack of a straightforward standardized protocol for their preparation. Cannabinoids, e.g., cannabidiol (CBD) and tetrahydrocannabinol (THC), have been shown to have therapeutic effects on various skin conditions, such as atopic dermatitis, psoriasis, scleroderma, acne and skin pigmentation. Recognizing the potential of dermatological treatment with medical cannabis, the present study aimed to evaluate the extraction capacity of various pharmaceutical bases for cannabinoids and the stability of prepared galenic formulations for dermatological applications with respect to cannabinoid content. The results showed that the stability of cannabinoids in formulations depended on the bases' physical and chemical properties. The highest THC decomposition was observed in cream bases and Vaseline, with estimated percentage loss of total content of up to 5.4% and 5.6% per week, respectively. In contrast, CBD was more stable than THC. Overall, the tested bases were comparably effective in extracting cannabinoids from plant material. However, olive oil and Synderman bases exhibited the highest cannabinoid extraction efficiencies (approximately 70%) and the best storage stabilities in terms of the content of monitored compounds. The proposed preparation protocol is fast and easily implementable in pharmacies and medical facilities.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Peč, Jaroslav $u Pharm & Herb s. r. o, Prostějov, Czechia
700    1_
$a Béres, Tibor $u Czech Advanced Technology and Research Institute, Palacký University, Olomouc, Czechia
700    1_
$a Štefelová, Nikola $u Czech Advanced Technology and Research Institute, Palacký University, Olomouc, Czechia
700    1_
$a Ćavar Zeljković, Sanja $u Czech Advanced Technology and Research Institute, Palacký University, Olomouc, Czechia $u Department of Genetic Resources for Vegetables, Medicinal and Special Plants, Centre of the Region Haná for Biotechnological and Agricultural Research, Crop Research Institute, Olomouc, Czechia
700    1_
$a Trojan, Václav $u Cannabis Facility, Centre for Translational Medicine, International Clinical Research Centre, St. Anne's University Hospital, Brno, Czechia
700    1_
$a Janatová, Anežka Kosmáková $u Department of Food Science, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Prague, Czechia
700    1_
$a Klouček, Pavel $u Department of Food Science, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Prague, Czechia
700    1_
$a Tarkowski, Petr $u Czech Advanced Technology and Research Institute, Palacký University, Olomouc, Czechia $u Department of Genetic Resources for Vegetables, Medicinal and Special Plants, Centre of the Region Haná for Biotechnological and Agricultural Research, Crop Research Institute, Olomouc, Czechia
773    0_
$w MED00174597 $t Frontiers in pharmacology $x 1663-9812 $g Roč. 14, č. - (2023), s. 1230728
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37593173 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231010 $b ABA008
991    __
$a 20231020093448 $b ABA008
999    __
$a ok $b bmc $g 1997180 $s 1201911
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 14 $c - $d 1230728 $e 20230801 $i 1663-9812 $m Frontiers in pharmacology $n Front Pharmacol $x MED00174597
LZP    __
$a Pubmed-20231010
Back

Find record

Citation metrics

Archiving options